Loading stock data…
Inspire Medical Systems (INSP)
$44.89-0.83 (-1.82%)
Market OpenUpdated 3:14 PM EDT
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Inspire Medical Systems, Inc. in the Healthcare sector is trading at $44.89 with a market capitalization of $1.2B. Wall Street consensus targets $50.92 (12 analysts), implying a +13.4% move over the next 12 months. The stock is currently near its 52-week low of $38.91, remaining 37.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +13.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $204.58M↓ | $269.08M↑ | $224.50M↑ | $217.09M↑ | $201.32M |
| Gross Profit | $176.91M↓ | $233.01M↑ | $192.73M↑ | $182.41M↑ | $170.61M |
| Operating Income | -$1.12M↓ | $46.11M↑ | $9.64M↑ | -$3.32M↓ | -$1.49M |
| Net Income | -$11.29M↓ | $136.09M↑ | $9.93M↑ | -$3.59M↓ | $2.99M |
Peer Comparison
JNJUNHPFE
Fundamentals
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.20B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
16.55%
Volume
Today's trading volume
366,067
Recent News
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 5.2% gain for healthcare stocks has fallen short of the S&P 500’s 8.5% rise.
INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026
Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
Alphatec bets on integrated spine surgery tech, while Inspire leads in sleep apnea devices with robust profitability. How do their financials and risks stack up?
3 Stocks Under $50 We Steer Clear Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.